Subscribe
Friday, April 3, 2026
30.4 C
Bengaluru
type here...
Subscribe

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Featured Article Anup Soans -
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in Indian Pharma? Executive Summary The Indian Pharmaceutical...
Exclusive Report

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
AI in Healthcare

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

0
When drones first appeared on battlefields, military establishments reacted...
Biologics

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Exclusive Articles

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

0
From Gas Cylinders to ICU Beds: How the Gulf...
Exclusive Articles

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

0
In the blistering Sonoran Desert, where temperatures regularly exceed...
Exclusive Articles

The Quiet Crisis in the Indian Pharma Field Force

0
A MedicinMan Editorial based on the Poll framed by...
Exclusive Report

The West Plays Precision Poker with High-stakes Specialty Drugs while India Plays Volume Chess with Portfolio Resilience

0
A recent industry spotlight by Venkat Mutavi notes a...
Indian Pharma Market Reports

IPM Powers Ahead in 2026: 11% Growth Fueled by Cardiac, Anti-Diabetics, and GLP-1 Stars

0
India's pharmaceutical market charged into 2026 with strong momentum,...

Topics

Don't Miss MedicinMan Updates

Hot this week

AI in Healthcare

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

0
1. Market Overview The oncology sector remains the most dominant...
AI in Healthcare

Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?

0
India’s diagnostics market is undergoing a quiet but profound...
spot_img

Follow Us

Popular Categories

Featured Article86Healthcare News51Exclusive Articles48Leaderspeak47Special Issue45Thought Leadership20

Video Insights

spot_imgspot_img

Headlines

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

Exclusive Articles Anup Soans -
In the blistering Sonoran Desert, where temperatures regularly exceed 100 degrees Fahrenheit, a sluggish, beaded lizard emerges from its...

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

Exclusive Articles Anup Soans -
India’s pharmaceutical industry occupies a unique and powerful position in global healthcare. It supplies nearly half of all generic...

Exclusive Articles

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs reshapes global pharma—and what it really means for Indian generics Executive...

Music

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

0
From Gas Cylinders to ICU Beds: How the Gulf...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

0
As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

0
Excellence is a choice. So is Mediocrity Excellence is a...

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

0
In the blistering Sonoran Desert, where temperatures regularly exceed...

Food

Excellence or Mediocrity—What Are You Building?

0
Excellence is a choice. So is Mediocrity Excellence is a...

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

0
In the blistering Sonoran Desert, where temperatures regularly exceed...

The Quiet Crisis in the Indian Pharma Field Force

0
A MedicinMan Editorial based on the Poll framed by...

The West Plays Precision Poker with High-stakes Specialty Drugs while India Plays Volume Chess with Portfolio Resilience

0
A recent industry spotlight by Venkat Mutavi notes a...

Samuel Paradise

Manuela Cole

Keisha Adams

George Pharell

spot_imgspot_img

Leaders Speak

Business leaders sharing their insights

Salil Kallianpur
Salil Kallianpur
14 POSTS
http://salilkallianpur.wordpress.com
K. Hariram
K. Hariram
8 POSTS
Deep Bhandari
Deep Bhandari
6 POSTS
Amaninder Dhillon
Amaninder Dhillon
6 POSTS
Raja Reddy
Raja Reddy
5 POSTS
Noumaan Qureshi
Noumaan Qureshi
5 POSTS
Arun Subramanian
Arun Subramanian
3 POSTS
https://www.enparadigm.com/
View More

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

0
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

0
How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk